Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2020; 30(02): 214-217
DOI: 10.4103/ijri.IJRI_17_19
Case Report

A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy

Shailendra S Naik
Departments of Radiodiagnosis, IRCH, AIIMS, New Delhi, India
,
Ilavarasi Vanidassane
Departments of Medical Oncology, IRCH, AIIMS, New Delhi, India
,
Ekta Dhamija
Departments of Radiodiagnosis, IRCH, AIIMS, New Delhi, India
,
Atul Sharma
Departments of Medical Oncology, IRCH, AIIMS, New Delhi, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
   Permissions and Reprints

Abstract

5-Fluorouracil (5-FU), a commonly used antimetabolite and antineoplastic agent, has been approved for the treatment of various cancers. It is associated with systemic side-effects such as gastrointestinal problems, neutropenia. 5-FU-related encephalopathy is very rarely reported. Imaging with computed tomography (CT) and magnetic resonance imaging (MRI) plays a key role in diagnosing and monitoring the changes. Since the prognosis of cerebral involvement is usually good if recognized and treated in time, the reporting radiologist and treating physician should be familiar with them. We present a rare case of 5-FU-induced encephalopathy that was diagnosed based on her clinical and MRI findings and managed successfully.

Keywords

Chemotherapy - drug-induced encephalopathy - encephalopathy - 5-fluorouracil


Publication History

Received: 17 January 2019

Accepted: 08 April 2020

Article published online:
19 July 2021

© 2020. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Acharya G, Carreras MT, Rice TW. 5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer. BMJ Case Rep 2017; 2017: bcr-2017-222030
    CrossrefPubMedGoogle Scholar
  • 2 Lee WW, Kim JS, Son KR, Kwon HM. Atypical diffusion-restricted lesion in 5-fluorouracil encephalopathy. Am J Neuroradiol 2012; 33: E102-3
    CrossrefPubMedGoogle Scholar
  • 3 Morales H, Tomsick T. Middle cerebellar peduncles: Magnetic resonance imaging and pathophysiologic correlate. World J Radiol 2015; 7: 438-47
    CrossrefPubMedGoogle Scholar
  • 4 Malhotra HS, Garg RK, Vidhate MR, Sharma PK. Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum. Ann Indian Acad Neurol 2012; 15: 151-7
    CrossrefPubMedGoogle Scholar